Zhizhong Pan

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 4

Top Topics

Fluorescent Probe

Metastatic Colorectal Cancer

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

European journal of human genetics : EJHG

Cancer communications (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Wenju Chang, Sheng Zhang, Baoqing Jia, Ke-Feng Ding, Zhizhong Pan, Guoqiang Su, Weiyuan Zhang, Tianyu Liu, Yun-Shi Zhong, Guodong He, Li Ren, Ye Wei, Dongdong Li, Xiao-Long Cui, Jun Yang, Yixiang Shi, Marc Bissonnette, Chuan He, Tripti Khare, Jia Fan, Jianmin Xu
A 5-Hydroxymethylcytosine-Based Noninvasive Model for Early Detection of Colorectal Carcinomas and Advanced Adenomas: The METHOD-2 Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Wenju Chang, Sheng Zhang, Baoqing Jia, Ke-Feng Ding, Zhizhong Pan, Guoqiang Su, Weiyuan Zhang, Tianyu Liu, Yun-Shi Zhong, Guodong He, Li Ren, Ye Wei, Dongdong Li, Xiao-Long Cui, Jun Yang, Yixiang Shi, Marc Bissonnette, Chuan He, Tripti Khare, Jia Fan, Jianmin Xu
A 5-hydroxymethylcytosine-based non-invasive model for early detection of colorectal carcinomas and advanced adenomas: the METHOD-2 study. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Binyi Xiao, Jun Luo, E Xie, Lingheng Kong, Jinghua Tang, Dingxin Liu, Linlin Mao, Qiaoqi Sui, Weirong Li, Zhigang Hong, Zhizhong Pan, Wu Jiang, Pei-Rong Ding
Comparisons of screening strategies for identifying Lynch syndrome among patients with MLH1-deficient colorectal cancer. European journal of human genetics : EJHG 28 (11) (2020)
Jianhong Peng, Weihao Li, Rongxin Zhang, Junzhong Lin, Jinghua Tang, Yongshan Wen, Zhenhai Lu, Xiaojun Wu, Zhizhong Pan
Safety and efficacy of a modified XELOX adjuvant regimen for patients with operated stage III colon cancer: a Chinese single-center experience. Cancer communications (London, England) 39 (1) (2019)